IMR Press / CEOG / Special Issues / 1634728335093

Sarcopenia and Women Health in the Elderly

Submission deadline: 31 December 2022
Special Issue Editors
Tae-Hee Kim, MD, PhD
Departments of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, 14584 Bucheon, Korea
Interests: Pregnancy; Menopause; Endometriosis; Placenta; Nutrition
Hee-Sook Lim, MD
Department of Gerontology, Graduate School of East-West Medical Science, Kyung Hee University, Republic of Korea
Interests: Aging; Clinical nutrition; AgeTech service; Sarcopenia; Chronic disease
Special Issue Information

Dear Colleagues,

Sarcopenia is an important health problem that reduces quality of life and increases medical expenses in the elderly due to decreased exercise capacity, decreased physical function, increased risk of falls and fractures, decreased ability to perform daily activities, and increased risk of death. It has been reported that the presence of sarcopenia affects muscle protein dynamics, oxidative capacity, increases body fat mass, and more than doubles the risk of abdominal obesity, diabetes, dyslipidemia, hypertension, metabolic syndrome, and cardiovascular disease. Muscle mass decreases by 1-2% every year after the age of 40, and muscle strength by 1.5% every year, which accelerates after age 60. At age 80, about 50% is lost compared to age 30. This is especially true for women as estrogen plays an important role in maintaining muscle mass. Most of the studies analyzing the relationship between sarcopenia and dietary factors have been conducted on the elderly. However, age-related changes in body composition, such as loss of muscle mass and increase in body fat, begin during middle age and progress gradually. Also, after menopause, hormonal changes increase the risk of sarcopenia in women. Therefore, in this study, we analyzed dietary factors related to sarcopenia, a common disease in middle-aged and elderly women over the age of 50, who began senile sarcopenia. We identified a correlation with elevated risk of metabolic disease.

Prof. Dr. Tae-Hee Kim and Dr. Hee-Sook Lim

Guest Editors

Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top